In vivo, ex vivo and in vitro dasatinib activity in chronic lymphocytic leukemia

Dasatinib inhibits the breakpoint cluster region-Abelson murine leukemia 1 (BCR-ABL1) gene along with other kinases known to be overexpressed and abnormally active in patients with chronic lymphocytic leukemia (CLL). The current study used primary leukemic cells obtained from 53 patients with CLL th...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Oncol Lett
Huvudupphovsmän: Giannopoulos, Krzysztof, Karczmarczyk, Agnieszka, Karp, Marta, Bojarska-Junak, Agnieszka, Kosior, Kamila, Kowal, Małgorzata, Tomczak, Waldemar, Hus, Marek, Machnicki, Marcin, Stokłosa, Tomasz
Materialtyp: Artigo
Språk:Inglês
Publicerad: D.A. Spandidos 2021
Ämnen:
Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7905539/
https://ncbi.nlm.nih.gov/pubmed/33732361
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2021.12546
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk